☰

Elizabeth Tarasewicz, Ph.D. - Publications

Affiliations: 
2014 Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Cell Biology, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Tarasewicz E, Oakes RS, Aviles MO, Straehla J, Chilton KM, Decker JT, Wu J, Shea LD, Jeruss JS. Embryonic Stem Cell Secreted Factors Decrease Invasiveness of Triple-Negative Breast Cancer Cells Through Regulome Modulation. Cancer Biology & Therapy. 0. PMID 29053396 DOI: 10.1080/15384047.2017.1385681  0.696
2014 Tarasewicz E, Rivas L, Hamdan R, Dokic D, Parimi V, Bernabe BP, Thomas A, Shea LD, Jeruss JS. Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells. Cell Cycle (Georgetown, Tex.). 13: 3191-201. PMID 25485498 DOI: 10.4161/15384101.2014.950126  0.765
2014 Tarasewicz E, Hamdan R, Straehla J, Hardy A, Nunez O, Zelivianski S, Dokic D, Jeruss JS. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. Cancer Biology & Therapy. 15: 1301-11. PMID 25006666 DOI: 10.4161/Cbt.29693  0.73
2013 Tarasewicz E, Rivas L, Hamdan R, Shea L, Jeruss J. Abstract P6-04-12: CDK inhibition mediates tumor suppressive Smad3 action and decreased metastatic phenotypes in triple negative breast cancer cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-04-12  0.762
2013 Hamdan R, Tarasewicz E, Nunez O, Straehla J, Hardy A, Zelivianski S, Jeruss J. Combined CDK4 Inhibition and Doxorubicin Restores Smad3 Tumor Suppression and Induces Apoptosis Via a Survivin-Associated Mechanism Journal of Surgical Research. 179: 341. DOI: 10.1016/J.Jss.2012.10.800  0.576
2013 Tarasewicz E, Rivas L, Jeruss J. Inhibition of CDK Mediated Smad3 Phosphorylation Results in Decreased Oncogenic Phenotypes in Triple Negative Breast Cancer Cells Journal of Surgical Research. 179: 254-255. DOI: 10.1016/J.Jss.2012.10.482  0.748
2012 Tarasewicz E, Jeruss JS. Phospho-specific Smad3 signaling: impact on breast oncogenesis. Cell Cycle (Georgetown, Tex.). 11: 2443-51. PMID 22659843 DOI: 10.4161/Cc.20546  0.71
2012 Tarasewicz E, Aviles M, Shea LD, Jeruss JS. Abstract 3241: Analysis of transcription factor activation by the embryonic microenvironment in metastatic breast cancer cells Cancer Research. 72: 3241-3241. DOI: 10.1158/1538-7445.Am2012-3241  0.655
2012 Tarasewicz E, Hardy A, Zelivianski S, Jeruss J. Impact of CDK4 Inhibition and Chemotherapy on Smad3 Action in Breast Cancer Cell Proliferation and Migration Journal of Surgical Research. 172: 229-230. DOI: 10.1016/J.Jss.2011.11.347  0.733
2011 Tarasewicz E, Hardy A, Straehla J, Foucar C, Zelivianski S, Jeruss J. P2-02-06: Inhibition of CDK4 Phosphorylation of Smad3 Decreases Cyclin D Overexpressing Breast Cancer Cell Proliferation and Migration. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-02-06  0.733
Show low-probability matches.